enovis - Robuta Search

https://markets.businessinsider.com/news/stocks/update-enovis-announces-fourth-quarter-and-full-year-2025-results-1035871594 Update: Enovis Announces Fourth Quarter and Full Year 2025 Results | Markets Insider Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically Full year 2025 Reconstructive sales gr... fourth quarter https://enovis-medtech.eu/en_US/index.html Enovis International Enovis is a global leader in medical technology. This site is your official contact point outside the US for innovative orthopedic, rehab and surgical devices. enovis international https://markets.businessinsider.com/news/stocks/enovis-initiated-with-a-buy-at-freedom-capital-1035651449 Enovis initiated with a Buy at Freedom Capital | Markets Insider Freedom Capital analyst Keith Hinton initiated coverage of Enovis (ENOV) with a Buy rating and $45 price target The orthopedics-focused medtech... freedom capital markets buy at enovis initiated insider https://markets.businessinsider.com/news/stocks/enovis-participates-in-a-conference-call-with-jpmorgan-1035880808 Enovis participates in a conference call with JPMorgan | Markets Insider in a conference call enovis participates jpmorgan https://markets.businessinsider.com/news/stocks/enovis-raises-fy25-adjusted-eps-view-to-3-10--3-25-from-3-05--3-20-1035506956 Enovis raises FY25 adjusted EPS view to $3.10-$3.25 from $3.05-$3.20 | Markets Insider FY25 consensus $3.13. Enovis (ENOV) updated financial expectations for 2025. Revenue is expected to be in the range of $2.24-2.27 billion, versu... https://markets.businessinsider.com/news/stocks/canaccord-genuity-reaffirms-their-buy-rating-on-enovis-enov-1035879851 Canaccord Genuity Reaffirms Their Buy Rating on Enovis (ENOV) | Markets Insider Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating on Enovis today and set a price target of $50.00.Claim 50% Off TipRanks Premium... canaccord genuity buy https://markets.businessinsider.com/news/stocks/enovis-enov-initiated-with-a-buy-at-freedom-capital-markets-1035651461 Enovis (ENOV) Initiated with a Buy at Freedom Capital Markets | Markets Insider In a report released today, from Freedom Capital Markets initiated coverage with a Buy rating on Enovis and a price target of $45.00.Claim 50% ... freedom capital markets buy at enovis initiated https://enovisrehab.com.au/ Enovis Rehab Australia Enovisis the leading supplier of orthopedic bracing and rehabilitation solutions enovis rehab australia https://markets.businessinsider.com/news/stocks/enovis-initiated-with-a-buy-at-freedom-capital-1035651410 Enovis initiated with a Buy at Freedom Capital | Markets Insider Freedom Capital initiated coverage of Enovis (ENOV) with a Buy rating and $45 price target Claim 50% Off TipRanks Premium and Invest with Confid... freedom capital markets buy at enovis initiated insider https://markets.businessinsider.com/news/stocks/enovis-initiated-with-a-buy-at-btig-1035687474 Enovis initiated with a Buy at BTIG | Markets Insider BTIG analyst Ryan Zimmerman initiated coverage of Enovis (ENOV) with a Buy rating and $41 price target The multi-segment orthopedics company of... with a buy at enovis initiated btig